Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide 10 mg is one of the mid-to-higher doses in the Mounjaro treatment schedule, and its cost in the UK private market typically sits in the upper half of the dose range — broadly within the £200–£375 per four-week pen bracket reported since Eli Lilly revised list prices in September 2025, though the figure you see from any provider depends on what that price actually covers. As with all doses of this prescription-only medicine, access requires a clinical assessment; a prescriber, not a checkout, decides whether 10 mg is appropriate for you at that point in treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide is dispensed as a single pre-filled KwikPen containing four weekly doses, and Eli Lilly sets a UK list price for each strength separately. When Lilly revised those list prices from 1 September 2025, the jump between lower and higher strengths widened noticeably, the highest-dose pen's list price moved from around £122 to around £330, with figures across the range shifting proportionally. Ten milligrams sits two steps below the 15 mg ceiling, so its private retail price lands meaningfully above the 5 mg pen but below the top of the range.
Private providers set their own margins on top of that list price, which is why quoted figures vary. The broader picture of tirzepatide costs across all doses explains the full range; for the 10 mg dose specifically, you can find a detailed breakdown of what 10 mg tirzepatide costs in the current private market, which reflects the realistic pricing since the September 2025 repricing. These figures are hedged for a reason: prices move, and the number on a provider's website may or may not include a prescription fee, a clinical consultation, aftercare or delivery. Worth checking before you commit.
NICE's appraisal of tirzepatide (TA1026) sets the clinical bar for NHS access, but private routes price independently of that framework.
A quoted monthly figure can look straightforward until you read the small print. Many providers charge separately for the initial consultation, the prescription itself, clinical follow-up before a dose increase, and delivery. Add those together and the gap between a cheap-looking headline price and an all-in price closes quickly, sometimes disappearing entirely.
At the 10 mg stage, patients are typically mid-treatment, which means dose-review support matters more than it did at 2.5 mg or 5 mg. If your provider charges separately for each clinical review before stepping you up, or bills for aftercare calls, that's a recurring cost the headline price never shows. It can help to compare against what tirzepatide 2.5 mg costs at the start of treatment and what the 5 mg dose typically costs to understand how far prices climb across a full titration.
Delivery charges also vary. Some providers quote free delivery only on orders above a threshold; others bill for tracked or next-day options. The Mounjaro pricing overview breaks down how these components combine across the treatment journey, and the 15 mg cost page shows where the top of the range sits if you're planning ahead.
The NHS notes that tirzepatide is a prescription-only medicine requiring clinical assessment at every stage, that assessment has to be accounted for somewhere in the price. If it isn't visible, it's worth asking where it went.
We don't publish per-pen prices in page copy (current treatment pricing is shown on our treatment page) but the structure is straightforward. One price covers your consultation, prescription, medicine, next-working-day DPD delivery and 7-day aftercare. No subscription. No separate fees layered on top. Every repeat order is clinically re-reviewed before it ships, which matters at the 10 mg dose when your prescriber needs to confirm that your current progress and tolerability support continuing.
We are not the cheapest option in the market, and that's a deliberate choice. The pen goes into the fridge when it arrives, and it stays there between weekly doses, but the clinical relationship around it is what makes a prescription medicine safe to use long-term. Speed and safety don't have to be in tension: order before 12 pm on a working day and, once approved, your treatment goes out the same day with DPD tracking to your door.
Our clinical team's approach is described on the prescriber profile page for anyone who wants to know more about who reviews each consultation. You can also read about us to see how the pharmacy is set up.
For most purchases, price is a perfectly sensible filter. A prescription medicine at the 10 mg stage of a titration schedule is not most purchases. The question that matters is whether you're getting genuine medicine through the licensed UK supply chain, dispensed by a GPhC-registered pharmacy, after a real clinical assessment.
The MHRA has been explicit about this risk: counterfeit weight-loss pens have been seized in large quantities across the UK, and fake pens have been found to contain insulin instead of tirzepatide. Sellers offering prescription medicines without a clinical assessment, via social media or at prices far outside the market range, are red flags the MHRA has specifically flagged. You can verify any online pharmacy on the GPhC pharmacy register, our registration number is 9012878. Report suspect sellers via the Yellow Card scheme.
A small saving per pen is not the measure that keeps you safe on a medicine you'll be taking weekly for months. The weight-loss treatment overview covers what a properly supervised programme looks like, and the FAQs address common questions about getting started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.